Literature DB >> 10229428

A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis.

A Spoorenberg1, D van der Heijde, E de Klerk, M Dougados, K de Vlam, H Mielants, H van der Tempel, S van der Linden.   

Abstract

To determine whether the Bath Ankylosing Spondylitis Functional Index (BASFI, score 0-10) or Dougados Functional Index (DFI, score 0-40) is superior in measuring physical function in ankylosing spondylitis (AS) we studied 191 consecutive outpatients with AS in the Netherlands, France, and Belgium. The participating centers are secondary and tertiary referral centers. The external criterion for disease activity (DA) was: both patient and physician assessment of disease activity on a visual analog scale (VAS) and the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). The external criterion for damage was 2 radiological scores of the spine; BASRI-s (Bath Ankylosing Spondylitis Radiology Index-spine) and a modified SASSS (Stoke Ankylosing Spondylitis Spine Score). Median scores for BASFI and DFI were 2.5 (range 0-10) and 8.5 (range 0-35), respectively. Spearman correlation coefficient between both indexes was 0.89. The average correlation with disease activity variables was 0.42 for BASFI and 0.41 for DFI. For both BASFI and DFI the correlation with BASRI-s was 0.42 and with SASSS 0.36. When distinguishing between patients with high and low disease activity, sensitivity for both indexes was between 76 and 94%, while specificity was between 66 and 87% for all 3 DA measures. Average misclassification between BASFI, DFI and DA was 23 and 27%, respectively. Both BASFI and DFI correlate equally well with disease activity and damage.

Entities:  

Mesh:

Year:  1999        PMID: 10229428

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  23 in total

1.  Tenascin-C, a biomarker of disease activity in early ankylosing spondylitis.

Authors:  Latika Gupta; Shruti Bhattacharya; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2018-01-08       Impact factor: 2.980

2.  Definition of disease duration in ankylosing spondylitis.

Authors:  Ernst Feldtkeller; Jon Erlendsson
Journal:  Rheumatol Int       Date:  2007-12-12       Impact factor: 2.631

Review 3.  Clinical observations programme in SpA: disease parameters, treatment options and practical management issues.

Authors:  Dirk Elewaut; Filip Van den Bosch; Gust Verbruggen; Filip de Keyser; Bert Vander Cruyssen; Herman Mielants
Journal:  Rheumatol Int       Date:  2008-09-26       Impact factor: 2.631

4.  Occupational physical activities and long-term functional and radiographic outcomes in patients with ankylosing spondylitis.

Authors:  Michael M Ward; John D Reveille; Thomas J Learch; John C Davis; Michael H Weisman
Journal:  Arthritis Rheum       Date:  2008-06-15

5.  Risk factors for functional limitations in patients with long-standing ankylosing spondylitis.

Authors:  Michael M Ward; Michael H Weisman; John C Davis; John D Reveille
Journal:  Arthritis Rheum       Date:  2005-10-15

6.  Elevated levels of serum MRP8/14 in ankylosing spondylitis: associated with peripheral arthritis and active disease.

Authors:  Latika Gupta; Shruti Bhattacharya; Vikas Agarwal; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2016-10-13       Impact factor: 2.980

7.  Evaluation of the Turkish version of the Dougados functional index in ankylosing spondylitis.

Authors:  Huseyin T E Ozer; Tunay Sarpel; Bozkurt Gulek; Z Nazan Alparslan; Eren Erken
Journal:  Rheumatol Int       Date:  2005-03-02       Impact factor: 2.631

8.  Which patients with ankylosing spondylitis should be treated with tumour necrosis factor inhibiting therapy? A survey among Dutch rheumatologists.

Authors:  R Landewé; B Rump; D van der Heijde; S van der Linden
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

9.  The Turkish versions of the Bath Ankylosing Spondylitis and Dougados Functional Indices: reliability and validity.

Authors:  Altinay Goksel Karatepe; Yesim Akkoc; Servet Akar; Yesim Kirazli; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2004-07-10       Impact factor: 2.631

10.  Regional radiographic damage and functional limitations in patients with ankylosing spondylitis: differences in early and late disease.

Authors:  Michael M Ward; Thomas J Learch; Lianne S Gensler; John C Davis; John D Reveille; Michael H Weisman
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-02       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.